141 related articles for article (PubMed ID: 2060128)
1. Cyclosporine analogues.
Jeffery JR
Clin Biochem; 1991 Feb; 24(1):15-21. PubMed ID: 2060128
[TBL] [Abstract][Full Text] [Related]
2. Production of less chronic nephrotoxicity by cyclosporine G than cyclosporine A in a low-salt rat model.
Burdmann EA; Rosen S; Lindsley J; Elzinga L; Andoh T; Bennett WM
Transplantation; 1993 May; 55(5):963-6. PubMed ID: 8497907
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
Rayat G; Yatscoff R; Silverman R; McKenna R
Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
[TBL] [Abstract][Full Text] [Related]
4. Evidence that cyclosporine G is less deleterious to rat bone in vivo than cyclosporine A.
Stein B; Takizawa M; Schlosberg M; Movsowitz C; Fallon M; Berlin JA; Epstein S
Transplantation; 1992 Mar; 53(3):628-32. PubMed ID: 1549857
[TBL] [Abstract][Full Text] [Related]
5. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
Burdmann EA; Andoh TF; Rosen S; Lindsley J; Munar MY; Elzinga LW; Bennett WM
Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and tolerability of cyclosporine G in human kidney transplant recipients.
Huser B; Thiel G; Oberholzer M; Beveridge T; Bianchi L; Mihatsch MJ; Landmann J
Transplantation; 1992 Jul; 54(1):65-9. PubMed ID: 1631947
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC
J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A versus cyclosporine G: a comparative study of survival, hepatotoxicity, nephrotoxicity, and splenic atrophy in BALB/c mice.
Masri MA; Naiem M; Pingle S; Daar AS
Transpl Int; 1988 Apr; 1(1):13-8. PubMed ID: 3254185
[TBL] [Abstract][Full Text] [Related]
9. A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats.
Duncan JI; Thomson AW; Simpson JG; Davidson RJ; Whiting PH
Transplantation; 1986 Oct; 42(4):395-9. PubMed ID: 3765053
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cytokine production by cyclosporine A and G.
McKenna RM; Szturm K; Jeffery JR; Rush DN
Transplantation; 1989 Feb; 47(2):343-8. PubMed ID: 2493179
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity of cyclosporine A and cyclosporine G in a rat model.
Tejani A; Lancman I; Pomrantz A; Khawar M; Chen C
Transplantation; 1988 Jan; 45(1):184-7. PubMed ID: 3336915
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat.
Kawashima H; Mochizuki M; Okumura A; Fujino Y; Tange T; Horiuchi D; Higashihara E; Kaku H; Inaba G
Jpn J Ophthalmol; 1989; 33(4):425-40. PubMed ID: 2625778
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporines: correlation of immunosuppressive activity and inhibition of bone resorption.
Stewart PJ; Stern PH
Calcif Tissue Int; 1989 Oct; 45(4):222-6. PubMed ID: 2509009
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
[TBL] [Abstract][Full Text] [Related]
15. A comparison of cyclosporine A and Nva2-cyclosporine (cyclosporine G) in a rat renal allograft model.
Grant D; Zhong R; Stiller C; Wallace C; Keown P; Duff J
Transplantation; 1987 Jul; 44(1):9-12. PubMed ID: 3299927
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of cyclosporin A, cyclosporin G, and the novel cyclosporin derivative IMM 125 in isolated glomeruli and cultured rat mesangial cells: a morphometric analysis.
Potier M; Wolf A; Cambar J
Nephrol Dial Transplant; 1998 Jun; 13(6):1406-11. PubMed ID: 9641169
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.
Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
J Med Chem; 2002 Oct; 45(21):4613-28. PubMed ID: 12361388
[TBL] [Abstract][Full Text] [Related]
18. Two new cyclosporin folds observed in the structures of the immunosuppressant cyclosporin G and the formyl peptide receptor antagonist cyclosporin H at ultra-high resolution.
Potter B; Palmer RA; Withnall R; Jenkins TC; Chowdhry BZ
Org Biomol Chem; 2003 May; 1(9):1466-74. PubMed ID: 12926274
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of effects of cyclosporins A and G on collagen arthritis in mice.
Takagishi K; Yamamoto M; Miyahara H; Hotokebuchi T; Kaibara N
Agents Actions; 1992 Nov; 37(3-4):284-9. PubMed ID: 1295377
[TBL] [Abstract][Full Text] [Related]
20. Effects of low and high density lipoproteins on renal cyclosporine A and cyclosporine G disposition in the isolated perfused rat kidney.
Strong ML; Ueda CT
Pharm Res; 1997 Oct; 14(10):1466-71. PubMed ID: 9358563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
